Evidence map›Paper›PMID 33017415›Full record

ArticlePloS one2020

Hybrid algorithms for generating optimal designs for discriminating multiple nonlinear models under various error distributional assumptions.

Ray-Bing Chen, Ping-Yang Chen, Cheng-Lin Hsu, Weng Kee Wong

Abstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Metaheuristics for pharmacometrics.CPT: pharmacometrics & systems pharmacology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ray-Bing ChenDepartment of Statistics, National Cheng Kung University, Tainan, Taiwan.
Ping-Yang ChenDepartment of Statistics, National Cheng Kung University, Tainan, Taiwan.
Cheng-Lin HsuDepartment of Statistics, National Cheng Kung University, Tainan, Taiwan.
Weng Kee WongDepartment of Biostatistics, University of California, Los Angeles, California, United States of America.ORCID 0000-0001-5568-3054

Funding

Designing Efficient Designs under Model Uncertainty for Biological StudiesR01GM107639 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WONG, WENG K · 2014 to 2017
$1.0M
NIGMS NIH HHS R01 GM107639
6 · The paper itself

Abstract

Finding a model-based optimal design that can optimally discriminate among a class of plausible models is a difficult task because the design criterion is non-differentiable and requires 2 or more layers of nested optimization. We propose hybrid algorithms based on particle swarm optimization (PSO) to solve such optimization problems, including cases when the optimal design is singular, the mean response of some models are not fully specified and problems that involve 4 layers of nested optimization. Using several classical examples, we show that the proposed PSO-based algorithms are not models or criteria specific, and with a few repeated runs, can produce either an optimal design or a highly efficient design. They are also generally faster than the current algorithms, which are generally slow and work for only specific models or discriminating criteria. As an application, we apply our techniques to find optimal discriminating designs for a dose-response study in toxicology with 5 possible models and compare their performances with traditional and a recently proposed algorithm. In the supplementary material, we provide a R package to generate different types of discriminating designs and evaluate efficiencies of competing designs so that the user can implement an informed design.

Indexed as

AlgorithmsData Interpretation, StatisticalDose-Response Relationship, DrugNonlinear DynamicsToxicity Tests

Identifiers

PMID33017415
PMCPMC7535070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.